Intuitive Surgical (NASDAQ:ISRG) Stock Gets Price Target Cut from Royal Bank Of Canada

Posted by George Bondi on Oct 24th, 2026

Intuitive Surgical (NASDAQ:ISRG – Free Report) had its target price reduced by Royal Bank Of Canada from $575.00 to $550.00 in a research report released on Wednesday, Marketbeat.com reports. They currently have an outperform rating on the medical equipment provider’s stock.

ISRG has been the topic of a number of other reports. Wall Street Zen downgraded shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Sunday, September 20th. Leerink Partners cut their price objective on shares of Intuitive Surgical from $573.00 to $454.00 and set an “outperform” rating on the stock in a report on Friday, July 17th. HSBC downgraded shares of Intuitive Surgical from a “buy” rating to a “hold” rating and set a $391.00 price objective for the company. in a research note on Thursday, July 30th. Citigroup lowered their target price on Intuitive Surgical from $590.00 to $500.00 and set a “buy” rating for the company in a report on Friday, July 17th. Finally, Oppenheimer restated an “outperform” rating and set a $500.00 target price on shares of Intuitive Surgical in a report on Wednesday. Twenty-three analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $493.54.

Check Out Our Latest Report on ISRG

Intuitive Surgical Price Performance

NASDAQ:ISRG opened at $452.29 on Wednesday. Intuitive Surgical has a 1-year low of $328.57 and a 1-year high of $603.88. The company has a 50-day moving average of $395.50 and a 200 day moving average of $409.13. The firm has a market cap of $156.78 billion, a PE ratio of 49.76, a price-to-earnings-growth ratio of 3.31 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last posted its earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 EPS for the quarter, beating analysts’ consensus estimates of $2.65 by $0.35. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The business had revenue of $3.05 billion for the quarter, compared to the consensus estimate of $2.91 billion. During the same quarter last year, the firm posted $2.40 EPS. The company’s revenue for the quarter was up 21.7% on a year-over-year basis. Sell-side analysts anticipate that Intuitive Surgical will post 8.87 EPS for the current fiscal year.

Insider Activity

In related news, EVP Mark Brosius sold 77 shares of Intuitive Surgical stock in a transaction on Friday, August 21st. The shares were sold at an average price of $375.57, for a total value of $28,918.89. Following the sale, the executive vice president owned 881 shares of the company’s stock, valued at approximately $330,877.17. This trade represents a 8.04% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gary Guthart sold 10,000 shares of Intuitive Surgical stock in a transaction on Tuesday, August 11th. The shares were sold at an average price of $400.00, for a total transaction of $4,000,000.00. Following the completion of the sale, the director directly owned 1,245,679 shares in the company, valued at $498,271,600. This represents a 0.80% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 12,370 shares of company stock worth $4,891,989. Insiders own 0.60% of the company’s stock.

Institutional Trading of Intuitive Surgical

Several institutional investors have recently modified their holdings of ISRG. Trueblood Wealth Management LLC raised its position in shares of Intuitive Surgical by 1.7% during the 3rd quarter. Trueblood Wealth Management LLC now owns 1,551 shares of the medical equipment provider’s stock worth $631,000 after purchasing an additional 26 shares during the last quarter. Norris Perne & French LLP MI lifted its stake in Intuitive Surgical by 118.2% in the 3rd quarter. Norris Perne & French LLP MI now owns 2,082 shares of the medical equipment provider’s stock valued at $847,000 after buying an additional 1,128 shares in the last quarter. Signaturefd LLC lifted its stake in Intuitive Surgical by 8.3% in the 3rd quarter. Signaturefd LLC now owns 7,582 shares of the medical equipment provider’s stock valued at $3,083,000 after buying an additional 582 shares in the last quarter. Corecam Pte. Ltd. boosted its holdings in Intuitive Surgical by 23.2% in the 3rd quarter. Corecam Pte. Ltd. now owns 690 shares of the medical equipment provider’s stock worth $281,000 after buying an additional 130 shares during the last quarter. Finally, McGuire Investment Group LLC boosted its holdings in Intuitive Surgical by 0.8% in the 3rd quarter. McGuire Investment Group LLC now owns 29,119 shares of the medical equipment provider’s stock worth $11,841,000 after buying an additional 224 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Key Headlines Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

Positive Sentiment: Intuitive Surgical reported third-quarter revenue of approximately $3.05 billion, up more than 20% year over year, while earnings exceeded consensus expectations. The company also highlighted continued international expansion and adoption of its robotic-surgery systems. Intuitive Surgical Stock: Margin Hit Masks Strong Q3 Growth Story
Positive Sentiment: Several firms remain constructive: BTIG, Stifel Nicolaus, Piper Sandler, and Oppenheimer reaffirmed or maintained Buy ratings. Baird also raised its price target, while Erste Group upgraded the stock to Buy. ISRG was added to the Zacks Rank #1 Strong Buy list. New Strong Buy Stocks for October 23rd
Neutral Sentiment: The quarter included roughly $450 million of costs tied to an antitrust settlement, along with pricing-related pressure, which reduced margins. These items appear largely nonrecurring, but investors are assessing their effect on near-term profitability. Intuitive Surgical Reports Q3 2026 Earnings Impacted by $450M Antitrust Settlement
Negative Sentiment: The key concern is that U.S. da Vinci procedure growth slowed to its lowest level since the COVID period. Investors worry that decelerating domestic demand could make it harder for Intuitive Surgical to sustain its premium valuation, which remains above 50 times earnings. Intuitive Surgical Sinks as U.S. da Vinci Growth Slows
Negative Sentiment: RBC lowered its expectations for ISRG, and an analyst downgrade contributed to a gap lower in the shares. The market is emphasizing forward growth and valuation rather than the headline earnings beat. Intuitive Surgical Shares Gap Down Following Analyst Downgrade

About Intuitive Surgical

(Get Free Report)

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company’s primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.